Currently, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease 2019 (COVID-19) has been reported in almost all countries globally, and no effective therapy has been documented for COVID-19 and the role of convalescent plasma therapy is unknown. In current study, 6 COVID-19 subjects with respiratory failure received convalescent plasma at a median of 21.5 days after first detection of viral shedding, all tested negative for SARS-CoV-2 RNA by 3 days after infusion, and 5 died eventually. In conclusion, convalescent plasma treatment can discontinue SARS-CoV-2 shedding but cannot reduce mortality in critically end-stage COVID-19 patients, and treatment should be initiated earlier.
Keywords: Convalescent plasma therapy; Coronavirus disease 2019 (COVID-19); Fatality; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Survival rate; Viral shedding.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: firstname.lastname@example.org.
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.JAMA. 2020 Mar 27;323(16):1582-9. doi: 10.1001/jama.2020.4783. Online ahead of print. JAMA. 2020. PMID: 32219428 Free PMC article.
The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients.J Med Virol. 2020 Apr 3. doi: 10.1002/jmv.25825. Online ahead of print. J Med Virol. 2020. PMID: 32243607
Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea.J Korean Med Sci. 2020 Apr 13;35(14):e149. doi: 10.3346/jkms.2020.35.e149. J Korean Med Sci. 2020. PMID: 32281317 Free PMC article.
Features, Evaluation and Treatment Coronavirus (COVID-19).2020 Apr 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan–. StatPearls. 2020 Jan–. PMID: 32150360 Free Books & Documents. Review.
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.Mil Med Res. 2020 Mar 13;7(1):11. doi: 10.1186/s40779-020-00240-0. Mil Med Res. 2020. PMID: 32169119 Free PMC article. Review.
Cited by 1 article
Perspectives of Immune Therapy in Coronavirus Disease 2019.J Korean Med Sci. 2020 May 11;35(18):e176. doi: 10.3346/jkms.2020.35.e176. J Korean Med Sci. 2020. PMID: 32383371 Free PMC article. Review.